Stay updated on Panitumumab, Nivolumab, Ipilimumab in mCRC Clinical Trial

Sign up to get notified when there's something new on the Panitumumab, Nivolumab, Ipilimumab in mCRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Panitumumab, Nivolumab, Ipilimumab in mCRC Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3; no visible changes to study details or navigation were observed.
    Difference
    0.1%
    Check dated 2026-03-06T18:54:58.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added to the page footer. Revision: v3.4.1 was removed.
    Difference
    0.1%
    Check dated 2026-02-13T12:58:30.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Revision history updated: a new entry for v3.4.1 was added and the existing entry for v3.4.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-06T09:14:50.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Added UI controls to show/hide the glossary (Show glossary / Hide glossary). Updated metadata labels and version information, including Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0, with capitalization adjustments.
    Difference
    0.3%
    Check dated 2026-01-22T17:42:19.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4. No visible changes to the study information on the page.
    Difference
    0.1%
    Check dated 2026-01-15T10:47:07.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    A consolidated Locations section now lists Florida, Indiana, North Carolina, Tennessee, and Washington. The HHS Vulnerability Disclosure link was removed, and the page revision updated to v3.3.3.
    Difference
    0.6%
    Check dated 2025-12-17T19:13:14.000Z thumbnail image

Stay in the know with updates to Panitumumab, Nivolumab, Ipilimumab in mCRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Panitumumab, Nivolumab, Ipilimumab in mCRC Clinical Trial page.